CCMH
INSY

Cornerstone Capital Management Holdings’s Insys Therapeutics, Inc. INSY Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,500
Closed -$59K – 1426
2016
Q4 		$59K Sell
6,500
-2,400
-27% -$27.1K ﹤0.01% 1270
2016
Q3 		$104K Buy
+8,900
New +$135K ﹤0.01% 1255
2016
Q1 		– Sell
-17,341
Closed -$497K – 1598
2015
Q4 		$497K Sell
17,341
-63,154
-78% -$1.75M ﹤0.01% 1039
2015
Q3 		$2.29M Buy
80,495
+42,795
+114% +$1.58M 0.02% 675
2015
Q2 		$1.35M Sell
37,700
-33,100
-47% -$1.03M 0.01% 817
2015
Q1 		$2.06M Buy
70,800
+36,000
+103% +$952K 0.02% 713
2014
Q4 		$733K Buy
34,800
+26,600
+324% +$526K 0.01% 926
2014
Q3 		$159K Sell
8,200
-13,000
-61% -$204K ﹤0.01% 1128
2014
Q2 		$331K Buy
21,200
+11,000
+108% +$178K ﹤0.01% 1045
2014
Q1 		$211K Sell
10,200
-15,000
-60% -$297K ﹤0.01% 1110
2013
Q4 		$325K Buy
+25,200
New +$350K ﹤0.01% 990

Other funds holding INSY

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCP
Fine Capital Partners New York $563M AUM 7.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Cornerstone Capital Management Holdings's INSY Position: Q1 2017 in Review

Cornerstone Capital Management Holdings sold out of Insys Therapeutics, Inc. (INSY) in Q1 2017, closing a stake of 6,500 shares — an estimated $59K sold.

Cornerstone Capital Management Holdings first reported a position in INSY in Q4 2013 and held it in 11 quarters. The position peaked at $2.29M in Q3 2015. 116 funds tracked by Wall St. Rank hold INSY as of Q1 2017.

  • Cornerstone Capital Management Holdings reported no remaining Insys Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 6,500 Insys Therapeutics, Inc. shares in Q1 2017, an estimated $59K.
  • Cornerstone Capital Management Holdings first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 11 quarters.
  • Cornerstone Capital Management Holdings's Insys Therapeutics, Inc. position peaked at $2.29M in Q3 2015.
  • 116 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q1 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2017, filed 10 May 2017.